Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. (SHE:300937)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceutical Wholesale - Terminal Pure Sales		2.33B	2.36B	2.37B	2.11B	1.64B
Pharmaceutical Wholesale - Terminal Pure Sales Growth		-1.32%	-0.36%	12.34%	29.07%	25.12%
Pharmaceutical Wholesale - Commercial Distribution		1.91B	1.97B	1.54B	1.25B	1.11B
Pharmaceutical Wholesale - Commercial Distribution Growth		-3.40%	28.05%	23.70%	12.01%	17.30%
Pharmaceutical Industry		40.16M	39.33M	12.68M	12.55M	-
Pharmaceutical Industry Growth		2.11%	210.10%	1.08%	-	-
Pharmaceutical Retail		68.42M	30.31M	19.59M	14.38M	25.98M
Pharmaceutical Retail Growth		125.76%	54.67%	36.25%	-44.66%	23.16%
health products, technologies and services		33.16M	23.54M	23.65M	16.23M	15.84M
health products, technologies and services Growth		40.88%	-0.48%	45.73%	2.49%	27.42%
Total		4.38B	4.43B	3.97B	3.40B	2.79B
Total Growth		-1.12%	11.62%	16.72%	21.88%	21.87%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China		4.38B	4.43B	3.97B	3.40B	2.79B
China Growth		-1.12%	11.62%	16.72%	21.88%	21.87%
Total		4.38B	4.43B	3.97B	3.40B	2.79B
Total Growth		-1.12%	11.62%	16.72%	21.88%	21.87%

Source: S&P Global Market Intelligence.